Treatment and risk factor analysis of hypoglycemia in diabetic rhesus monkeys

Experimental Biology and Medicine

Volumn 236, Issue 2, 2011, Pages 212-218

  He, Sirong ^a   Chen, Younan ^a   Wei, Lingling ^a   Jin, Xi ^a   Zeng, Li ^a   Ren, Yan ^a   Zhang, Jie ^a   Wang, Li ^b   Li, Hongxia ^b   Lu, Yanrong ^a   Cheng, Jingqiu ^a  

^a SICHUAN UNIVERSITY   (China)

^b National Chengdu Center for Safety Evaluation of Traditional Chinese Medicine   (China)

Author keywords

Diabetic monkey; Glycemic control; Hypoglycemia; Modeling method; Renal function

Indexed keywords

C PEPTIDE; CREATININE; DEXAMETHASONE; GLUCAGON; GLUCOSE; HYDROCORTISONE; INSULIN; KETAMINE; STREPTOZOCIN; TRIACYLGLYCEROL;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETOGENESIS; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPOGLYCEMIA; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MORBIDITY; NONHUMAN; PANCREAS RESECTION; PROTEIN BLOOD LEVEL; RHESUS MONKEY; RISK ASSESSMENT; STUDENT T TEST; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CREATININE; DIABETES COMPLICATIONS; DISEASE MODELS, ANIMAL; HYPOGLYCEMIA; MACACA MULATTA; RISK FACTORS; TRIGLYCERIDES;

ANIMALIA; MACACA MULATTA;

EID: 79951593414     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.010208     Document Type: Article

References (18)

1. The Diabetes Control and Complications Trial Research (DCCT) Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53
3. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care 2003;26:1902-12 (Pubitemid 36929141)
4. Cryer PE. Current concepts: diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 2004;50:2272-9
5. Kovatchev BP, Cox DJ, Kumar A, Gonder-Frederick L, Clarke WL. Algorithmic evaluation of metabolic control and risk of severe hypoglycemia in type 1 and type 2 diabetes using self-monitoring blood glucose data. Diabetes Technol Ther 2003;5:817-28 (Pubitemid 37339544)
6. Lu YR, Wang LN, Jin X, Chen YN, Cong C, Yuan Y, Li YC, Tang WD, Li HX, Wu XT, Li YP, Wang L, Cheng JQ. A preliminary study on the feasibility of gene expression profile of rhesus monkey detected with human microarray. Transplant Proc 2008;40:598-602 (Pubitemid 351406421)
7. Fujiyama A,Watanabe H, Toyoda A, Taylor TD, Itoh T, Tsai SF, Park HS, Yaspo ML, Lehrach H, Chen Z, Fu G, Saitou N, Osoegawa K, de Jong PJ, Suto Y, Hattori M, Sakaki Y. Construction and analysis of a human-chimpanzee comparative clone map. Science 2002;5:131-4 (Pubitemid 34052362)
8. Hering BJ, Wijkstrom M, Graham ML, Harstedt M, Aasheim TC, Jie T, Ansite JD, Nakano M, Cheng J, Li W, Moran K, Christians U, Finnegan C, Mills CD, Sutherland DE, Bansal-Pakala P, Murtaugh MP, Kirchhof N, Schuurman HJ. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006;12:301-3 (Pubitemid 43355076)
9. Qiao CF, Tian BL, Mai G, Wei LL, Jin X, Ren Y, Chen YX, Li HX, Li YP, Wang L, Cheng JQ, Lu YR. Induction of diabetes in rhesus monkeys and establishment of insulin administration strategy. Transplant Proc 2008;41:413-7
10. Koulmanda M. Islet transplant model in nonhuman primates: use of streptozotocin. Transplant Rev 2006;20:126-30 (Pubitemid 44276416)
11. Litwak KN, Cefalu WT, Wagner JD. Streptozotocin-induced diabetes mellitus in cynomolgus monkeys: changes in carbohydrate metabolism, skin glycation, and pancreatic islets. Lab Anim Sci 1998;48:172-8
12. Theriault BR, Thistlethwaite JR, Levisetti MG,Wardrip CL, Szot G, Bruce DS, Rilo H, Li XT, Gray GS, Bluestone JA, Padrid PA. Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascicularis). Transplantation 1999;68:331-7 (Pubitemid 29384099)
13. Jin X, Zeng L, He S, Chen Y, Tian B, Mai G, Yang G, Wei L, Zhang Y, Li H, Wang L, Qiao C, Cheng J, Lu Y. Comparison of single high-dose streptozotocin with partial pancreatectomy combined with low-dose streptozotocin for diabetes induction in rhesus monkeys. Exp Bio Med 2010;235:877-85
14. Schnedl WJ, Ferber S, Johnson JH, Newgard CB. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 1994;43:1326-33
15. Rood PPM, Bottino R, Balamurugan AN, Smetanka C, Ezzelarab M, Busch J, Hara H, Trucco M, Cooper DKC. Induction of diabetes in cynomolgus monkeys with high-dose streptozotocin adverse effects and early responses. Pancreas 2006;33:287-92 (Pubitemid 44470145)
16. Hadjadj S, Duly-Bouhanick B, Bekherraz A, Bridoux F, Gallois Y, Mauco G, Ebran JM, Marre M. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes. Diabetes Metab 2004;30:43-51 (Pubitemid 38418942)
17. Shumway JT, Gambert SR. Diabetic nephropathy - pathophysiology and management. Int Urol Nephrol 2002;34:257-64
18. Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12 (Pubitemid 30609442)